Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128697) titled 'Listening to the Body's Chemical Clues to Understand Migraine' on July 24.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Migraine
Intervention:
Episodic migraine:None
chronic migraine:None
medication-overuse headache:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-28
Target Sample Size: Episodic migraine:40; chronic migraine:40; medication-overuse headache:40; healthy controls:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...